Breast cancer associated with pregnancy. by Lynch, G. A.
BREAST CANCER ASSOCIATED WITH PREGNANCY
By GERARD A. LYNCH, M.B., F.F.R., F.F.R.(I.), D.M.R.T.
Northern Ireland Radiotherapy Centre, Montgomery House, Purdysburn, Belfast
THE ASSOCIATION of breast cancer with pregnancy is an infrequent one, and
whilst many reports in the past suggested that such an association led to an
almost hopeless situation, more recent re-appraisal indicates that where clinical
findings are identical the prognosis may be no different from that of a similar
group of non-pregnant breast cancer patients. It is suggested, indeed, that in some
circumstances pregnancy can have a favourable influence on the prognosis and it
is emphasised that radical or curative treatment should be attempted whenever
possible. Where pregnancy complicates breast cancer, however, it must be accepted
that there are many additional problems facing the surgeon, gynaecologist, radio-
therapist and family doctor. Should the pregnancy be terminated? Should the
young woman treated for breast cancer be advised against subsequent pregnancies?
Obviously, many factors other than purely clinical considerations must be taken
into account and these, together with the infrequency of the condition and the
degree of individualisation, necessarily plays havoc with any attempt to determine
a treatment policy. As further reports appear in the literature, however, it becomes
possible to indicate more positively what treatment measures and factors may
influence the prognosis and this present article reviews our experience in the
Northern Ireland Radiotherapy Centre over an eleven year period. The cases are
discussed and compared with similar groups already reported.
INCIDENCE
The figure most often quoted is that of T. T. White (1958) who, reviewing the
world literature, states that three cases of carcinoma of the breast occur per every
ten thousand pregnancies. In Northern Ireland over eleven years 45 cases of breast
cancer occurring in pregnancy and lactation were registered at the Radiotherapy
Centre whilst there were 337,000 births in the country in the same period.
TABLE I
Breast Cancer Associated with Pregnancy in Northern Ireland
Population 1.4 millions
Births 337,342
Breast Cancer in Pregnancy and Lactation registered at Centre 45 cases
Breast Cancer Cases Registered 3,031
Breast Cancer Associated with Pregnancy 59 cases
Pregnancy Complicating Breast Cancer (O/%) 1.9%
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This table indicates that one case of carcinoma of the breast occurs for every
7,500 births, a figure considerably lower than that of White but rather similar to
that of Finn (1952) who found 10 patients with breast cancer in 65,561 pregnancies.The high figure of White may be accounted for by the fact that he quotes reports
from several specialised units or hospitals where some degree of selection must
have been inevitable. The figures from Northern Ireland on the other hand include
all births in the country over that period, both hospital and domiciliary. In
addition, the radiotherapy service covers the whole country and approximately
90 per cent of all new breast cancers occurring are registered at the Radiotherapy
Centre. For geographical and other reasons there is very little population move-
ment or loss of clinical material.
The table also indicates that in the eleven year period just over 3,000 new breast
cancer cases were registered at the Radiotherapy Centre. In that time 59 patients
were seen in which pregnancy complicated the condition, i.e., 45 cases where breast
cancer appeared in pregnancy or lactation and 14 cases where pregnancy followed
previously treated breast cancer. The figure of 1.9 per cent is almost identical to
the 2 per cent figure quoted by White (1958) from several New York and Seattle
hospitals but lower than the 2.9 per cent given earlier by the same author in a
collected series of 43,931 cases (1955). These figures refer to breast cancer patients
of all ages but when the child bearing age is considered, then pregnancy compli-
cating breast cancer is not an uncommon occurrence. Most of the patients with this
combination must be found in the 30 to 40 age group and this was the case in this
present series (Tables 2 and 3).
TABLE II
Breast Cancer in Pregnancy and Lactation
Age 20-29 30-39 40-49
Number 3 26 16
Average Age=37.0 years
TABLE III
Breast Cancer Treated Prior to Pregnancy
Age 20-29 30-39 40-49
Number 3 8 3
Average Age=36.1 years
It was found that when we considered only breast cancer patients under the
age of 40, 19 per cent of the patients, or almost one in every five, had concurrent
pregnancy or became pregnant after treatment for breast cancer. This is a figure
very similar to that of Treves & Holleb (1958) who reviewed 549 patients, 35 years
of age or younger, finding that 14 per cent had concurrent pregnancy and 5.5 per
cent became pregnant after treatment for their breast cancer.
Our youngest patient was a woman of 25 and the oldest, a woman of 45 years
of age.
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The previous obstetric history of both groups of patients is illustrated in
Table IV.
TAKIE IV
Breast Cancer and Pregnancy. Obstetric History
Previous Cancer inPregnancy Pregnancyfollowing
Obstetric and Lactation Treated BreastCancer
History 45 Patients 14 Patients
Nulliparous 5 4
Para 1 9 4
Para 2 7
Para 3 11 2
Para 4 6 1
Para 5 3 2
Para 6+ 4 1
This indicates that 14 patients out of 45 where breast cancer appeared during
pregnancy or lactation, and 8 patients out of 14 where pregnancy followed previously
treated breast cancer, were nulliparous or had one child. This quite clearly is a factor
one would have to take into consideration on the question of therapeutic abortion
or the advisability of future pregnancies.
Of the 59 cases registered at the Centre, 45 were patients where the breast cancer
was seen either with pregnancy or lactation and 14 were patients where pregnancy
occurred following previous breast cancer treatment. In 37 of these patients it was
possible to produce a five year survival comparison and this is illustrated in Table V.
TABLE V
Numberof 5 Year Per cent
Category Cases Survival Survivors
(1) Onset before or during
pregnancy 21 7 33
(2) Onset during lactation 6 3 50
(3) Pregnancy following treated
breast cancer 10 4 40
(1) and (2) combined 27 10 37
PROGNOSIS
As in most other series the cases have been divided into three categories; (1)
where the carcinoma developed before or during pregnancy; (2) where the carcinoma
was observed during the period of lactation and (3) where pregnancy followed
previously treated breast cancer. From the point of view of 5 year survival it is
probably reasonable to combine the first two categories assuming that many
36carcinomas found in lactation were present and developed during pregnancy. As in
practically all other series the numbers, of course, are small but the 5 year survival,
37 per cent for categories (1) and (2) combined is almost identical to that of Peters
(1962) who reported 32.9 per cent in 70 cases. Figures from other series on 5 year
survival include White (1955) 16.3 per cent, and Byrd et al (1962), 55.2 per cent.
In many reports, however, it is difficult to determine overall 5 year survival rates
because of the many qualifications such as operability, presence or absence of
metastases, etc. The figures are certainly not very dissimilar to non-pregnant breast
cancer patients when comparable age groups and stages are matched.
Practically all previous reports have indicated that the prognosis is influenced to
a very great degree by the stage of pregnancy in which treatment was initiated.
Our experience is illustrated in Table VI.
TABLE VI
Stage of Pregnancy in which Breast Cancer was Treated
Numberof 5 Year Per cent
Stage of Pregnancy Cases Survival Survival
Treated in 1st Trimester 5 4 80
Treated in 2nd Trimester 3 1 33
Treated in 3rd Trimester 3 - -
Treated after Pregnancy 8 2 25
Untreated 2
TOTAL 21 7 33
This certainly suggests a higher survival rate in the first trimester and is very
much in keeping with the experience of others. White (1958) found 16.3 per cent
survivals in the first trimester, 8 per cent in the second and 9.7 per cent in the
third. Peters (1962) reported 25 per cent for the first trimester, none for the second
and 11 per cent for the third with a figure of 50 per cent for those treated after
the termination of pregnancy.
Prognosis, too, could obviously be expected to bear a relationship to clinical
staging and Table VII clearly confirms that the earlier the condition is detected
the better the prognosis.
TABLE VII
Survival in Relation to Clinical Stage
(Pregnancy and Lactation)
Number 5 YearSurvivors
Stage 1 8 5 (62.5%)
Stage 2 13 5 (38.5%)
Stage 3 3 0
Stage 4 3 0
37There were no survivors in the six cases found in Stage 3 and Stage 4 whilst in
the remaining 21 patients allocated to Stage 1 and Stage 2 there were 10 five year
survivors, i.e., 47.5 per cent. The importance of determining involvement of homo-
lateral axillary nodes will be referred to later.
PATHOLOGY
The pathology reports were not particularly helpful in this series, possibly because
of the fact that almost half of the patients were treated by simple mastectomy, but
it is interesting to note that there were 6 five year survivors out of 14 where the
tumour was described as 'anaplastic carcinoma', i.e., 43 per cent.
MANAGEMENT
The actual treatment methods or techniques carried out in this particular series
are illustrated in Table VIII. The table, if nothing else, demonstrates the involved
tortured thinking brought to bear on what can often be a very difficult problem.
Three patients were treated either by radiotherapy or some palliative procedure
whilst in the remaining 18, treatment was by mastectomy, either simple or radical,
in association with post-operative x-ray therapy, therapeutic abortion and/or
castration. Most other reports indicate that the prognosis is influenced to a very
great degree by the involvement of the homo-lateral axillary nodes, but in this
particular series 9 patients were treated by simple mastectomy and consequently
no information was available on this point. In the 9 patients treated by radical
mastectomy positive glands were reported in five and of these one survived five
years. In the other 4 patients with negative glands there were two five year survivors.
TABLE VIII




























PREGNANCY FOLLoWING TREATED BREAST CANCER
In this particular group there were 14 patients in which pregnancy occurred
following initial control of breast cancer. 10 patients were available for 5 year















This shows 4 five year survivors, i.e., 40 per cent. Peters reports 32 per cent
survivors out of 38, i.e., 72 per cent in a similar group, whilst White in a collected
series reports 59 per cent five year survival. The literature certainly suggests that
the prognosis in this particular group is good, but it must be kept in mind that this
is a very select group in that the very nature of the disease itself eliminates, at an
early stage, those patients with an aggressive form of cancer.
COMMENT
As more reports appear on the association of breast cancer and pregnancy the
previously held pessimistic views are being replaced, to some extent, by a more
optimistic approach to the problem. This present review would suggest or confirm
that a more hopeful outlook is not entirely unjustified, but, even accepting this, it
39has to be admitted that the combination often presents difficult, involved and, at
times, almost insoluble problems. The treatment of breast cancer, even in ideal
circumstances, can often be a depressing subject but, how much more so is it, when
the patient is in her early thirties, when she may have small children and when two
lives, not one, are perhaps dependent on the advice given or the decisions taken.
Anyone who has had to deal with these cases, will readily appreciate the many
considerable pressures that come into play so that rational thought and considered
approach to the problem are often very difficult.
How then should such patients be handled? Review of the present group of
patients and the literature would suggest that there is a great deal to be gained and
very little to be lost by not treating the situation as an emergency, necessiating
rapid and, perhaps, hasty decisions. A little delay, more observation of both patient
and tumour, an attempt at objective assessment, and full discussion with all others
possibly involved in treatment and management must be recommended even in
the most difficult and poignant presentation. Practically all authors emphasise, too,
that in the first instance, the pregnancy should be ignored altogether and the
patient assessed for treatment in the same manner as an uncomplicated breast
cancer patient. If the criteria are such as to indicate a radical or potentially
curable approach then the problem should be dealt with on this basis.
Earlier in referring to Table VI attention was drawn to the fact that, in this
series, and in reports from other centres notably those of Peters and White, the
results achieved in the treatment of patients in the latter half of pregnancy were
much worse than in those patients treated in the first few months. Recognising this,
Peters suggests that, whenever possible, radical treatment for cancer detected in
the second half of pregnancy should be delayed until the post-partum period at
which time there appears to be a much higher survival rate. Obviously, when the
initial diagnosis is made in the last few weeks of pregnancy there would be clear
advantages in a minimum period of delay until either Caesarean section or induction
were considered appropriate for safe delivery, but on the other hand, when diag-
nosed at an earlier stage it must be difficult not to recommend radical or definitive
treatment. It is certainly very hard to understand why results achieved in those
cases treated in the latter half of pregnancy should be so poor and also why delay
in the treatment of such patients until the post-partum period should, or could,
result in any appreciable improvement in results. It may possibly be that in the late
stages of pregnancy, surgery on a distended vascular breast is a traumatic insult of
such magnitude as to overwhelm the immune and other body defences, and certainly
the evidence is such, and the results so poor, as to suggest that serious consideration
be given to the policy advocated by Peters.
In this present series it can be seen that almost half the patients treated were
submitted to simple mastectomy followed by radical x-ray therapy. TIhis on
reflection, was probably not the best approach in many cases, for there are at
least two big advantages in radical mastectomy over simpler surgical procedures.
1. Following radical mastectomy there should, in most cases, be no question
of radiation therapy, whereas, with simple mastectomy, radiation is considered to
play a major role in treatment. Although the x-rays are directed to the upper chest
and shoulder, scatter is inevitable and in the Adrian Committee Report of 1960
we note that the gonadal dose received in the treatment of breast cancer has been
40estimated at 7.79r. It is not unreasonable to suggest that the foetus, in the early
stages of pregnancy and when most vulnerable must be exposed to a similar dose,
and this, in most circumstances, must be regarded as unacceptable.
2. In the radical mastectomy specimen an opportunity is afforded to determine
the involvement or otherwise of the homolateral axillary nodes. White (1955),
Miller (1962), Byrd et al (1962), Holleb and Farrow (1962) and Austin (1960)
all refer to this as a most important factor in determining prognosis. This, of course,
is true for non-pregnant breast cancer patients, but many reports on this particular
association indicate that the prognosis for those patients without metastases is five
to ten times better than those with metastases. Possession of such knowledge could,
then, be regarded as vitally important when further management is discussed not
alone with ones colleagues, but with the patient, the patient's husband or relatives.
The question of the termination of pregnancy inevitably arises in any discussion
on the management of these cases and indeed there has been considerable contro-
versy on the benefits of abortion. Many specialists have felt that immdiate termina-
tion of pregnancy would improve the survival rate but there is little or no
statistical evidence to confirm these views. The information available at present,
indeed, would appear to suggest that no clear benefit can be demonstrated from
abortion, and this is the view held by White (1955) in reviewing 1,375 cases from
144 published articles. A similar conclusion was reached by Peters (1962) in report-
ing 70 cases treated at the Ontario Cancer Institute, and a study of recent literature
would only appear to confirm this opinion. One accepts that there are many factors
to be taken into account in reaching a decision on this particular aspect of manage-
ment, but equally, in view of the present available evidence, one would hesitate
to recommend termination of pregnancy as a routine procedure in the operable
breast cancer patient.
Apart from the advisability of therapeutic abortion, radiation or surgical castra-
tion will almost certainly come into consideration in the treatment of these patients.
In assessing the possible benefits of such a procedure, it must be remembered that
oophorectomy, as far as we know, cannot be regarded as a curative measure in
the treatment of breast cancer. Review of the literature, too, would suggest that
there is no proof indicating that oophorectomy influences the survival rate in breast
cancer developing in pregnancy, and clearly there can be little or no indication for
recommending castration as a routine measure in early potentially curable cases.
Peters, indeed, suggests that in this particular instance the more favourable cases
in the younger age group would be deprived of the possible benefits of future preg-
nancies by such a procedure.
So far reference has only been made to those patients with an early curable breast
cancer discovered in pregnancy. If, on the other hand, the patient presents with
advanced local disease and/or metastases, then the real problems or difficulties
arise If this, indeed, is the position, there can be no one treatment policy to recom-
mend or follow but all the measures mentioned - surgery, radiation, therapeutic
abortion, hormone therapy, castration, pituitary ablation, and chemotherapy may
be tried singly or in combination. Invariably, the response to treatment recom-
mended is minimal and, in the circumstances, the policy must be one of
individualisation with many factors other than clinical ones, playing a more
important role in determining or influencing the advice given and the measures
41taken. Here indeed lies the real tragedy of breast cancer associated with pregnancy,
ror very often, in these circumstances, the apparently inevitable end result is the
death of both baby and mother. Such an outcome certainly must leave a lasting
impression on those associated with treatment and subsequently could very well
influence, adversely, individual judgment on the management of even the earliest
breast cancer in pregnancy. This, together with the low incidence of the particular
association would suggest that centralisation of treatment of such patients, would
almost certainly be beneficial. Not least of these benefits would be the fact that
sufficient numbers could be compiled to enable proper statistical evaluation of many
of the factors associated with treatment. One might best illustrate the infrequency
of the association by referring again to the figures here in Northern Ireland which
suggest that a general surgeon, on average, sees one such patient every eight to ten
years.
Finally, reference must be made to that group of patients where pregnancy
follows treatment for cancer of the breast. In this present series, there were 14 such
patients and ten were available for evaluation. Four of the 10 were alive and well
at five years. Here again numbers are very small, but reference has already been
made to the 72 per cent five year survival figure of Peters and the 59 per cent of
White in similar, but very much larger, groups. This would appear to be the
experience of others, and the overall figures are such as to suggest that patients in
this group do even better than breast cancer patients without pregnancy. This, of
course, is a select group in that the very nature of the breast cancer eliminates, at
an early stage, those patients with an aggressive form of the disease. Whilst this is
true, problems will still arise and before offering advice many factors should be
considered, i.e., age of patient, size of family, history and extent of the previously
treated breast cancer, involvement or otherwise of the homolateral axillary nodes,
the histologic grading and previous radiation or chemo-therapy. Many reports
would suggest that pregnancy should be delayed for two years following mastectomy
and although this is largely an arbitrary determination most would regard it as
reasonable. If, however, many of the prognostic factors mentioned are poor then
further delay should be advised for, indeed, one must keep in mind the fact that
the combination of recurrent and/or metastatic breast cancer and pregnancy is
truly a clinical catastrophe (Fig. 1) unlikely to be influenced to any degree by
present day therapy.
SUMMARY
Three thousand breast cancer cases, registered at the Northern Ireland Radio-
therapy Centre, were reviewed and pregnancy was found to complicate the condi-
tion in 59 patients, i.e., 2 per cent. Where only those patients under the age of 40
were considered 19 per cent had concurrent pregnancy or became pregnant after
treatment of their breast cancer. In 45 of the patients the breast cancer appeared
in pregnancy or lactation and in the remaining 14 pregnancy followed treatment
of a breast cancer.
Management is discussed and the advantages of radical mastectomy over
simpler surgical procedures is commented upon with the observation that radiation
therapy would appear to have little part to play in the treatment of early cases.
As in other series there was a higher survival rate in those cases treated in the
early months of pregnancy with therapeutic abortion and castration apparently
42having little or no bearing on the prognosis. It is suggested that these procedures,
if not actually contra-indicated, should certainly not be recommended routinely in
the operable or potentially curable patient.
In the cases reviewed it was noted that where breast cancer developed in preg-
nancy or lactation 37 per cent of the patients survived five years. This is a figure
rather similar to other recently published reports and suggests or confirms that the
prognosis, where breast cancer is associated with pregnancy, is not very different
from similar groups of non-pregnant patients. In the group of patients where
pregnancy followed previously treated breast cancer 40 per cent survived five years
and the many factors believed to be relevant to the prognosis, or to be considered
when advising on subsequent pregnancies are detailed. The review also indicates
that one case of breast cancer may be expected for every 7,500 births and it is
suggested that because of the infrequency of the condition and the many problems
involved in management centralisation of the treatment of such cases might be
usefully considered. The importance of objective discussion and assessment of
such patients on the same basis as the uncomplicated breast cancer case is stressed.
(Some of the points referred to in the discussion are illustrated in six case reports).
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43ILLUSTRATIVE CASE REPORTS
CASE 1. Patient M.M. Age 34. Para 3
History
6 months history of lump in the left breast.
Attended own doctor in December 1955 when she was 7-10 weeks pregnant.
Pre-Operative Findings






X-ray therapy February 1956
Pathology Report
Biopsy "Anaplastic spheroidal cell carcinoma".
No residual tumour found in mastectomy specimen.
Subsequent History
March 1958 fourth child born alive and well.
April 1959, fifth child born alive and well.
Well 8 years later.
Comment
Reflection and subsequent history suggests that if pregnancy had been allowed to proceed
disease would probably not have been activated.
CASE 2. Patient K.McC. Age 29. Para 4
History
Noted small swelling in right breast in July 1960. Referred to hospital.
Pre-Operative Findings
2 cm. mobile nodule in inner half of the right breast.
Treatment
Biopsy excision 6.8.1960.
X-ray therapy August 1960.
Pathology Report
"Anaplastic spheroidal cell carcinoma".
Subsequent History
Well until April 1963 when she became pregnant.
In June 1963 complained of bleeding from the nipple.
Mastectomy performed June 1963. Pathology report showed "Intraduct carcinoma".
Fifth child delivered December 1963-alive and well.
No evidence of recurrence or metastases three years later.
Comment
Apparent reactivation of disease during pregnancy.
44CASE 3. Patient D.C. Age 36. Para 5
History
Noted lump in upper outer quadrant of right breast in August 1955. Showed it to own
doctor and was operated on seven days later.
Pre-Operative Findings




Radical mastectomy August 1955.
X-ray therapy September/October 1955.
Pathology Report
"Anaplastic spheroidal cell carcinoma" commencing in intraduct carcinoma but infiltrat-
ing widely. Nodes clear.
Subsequent History
In April 1956 was delivered of stillborn macerated baby.
Further child 1961.
Well 9 years after initial diagnosis.
Comment
Note stage of pregnancy at which x-ray therapy was administered. To-day such a case
would almost certainly not be treated by post-operative radiation.
CASE 4. Patient M.H.. Age 39. Para 1
History
In December 1958 patient noticed three small nodules in the right breast. Attended owIl
doctor and referred immediately to hospital.
Pre-Operative Findings






X-ray therapy February 1959.
Pathology Report
"Extensive infiltration by a spheroidal cell carcinoma which had originated in wide-
spread intraduct carcinoma but which is now infiltrating".
Subsequent History
Twins born 2.8.1959-six weeks premature.
First child stillborn and macerated.
Well 5 years later.
Comment
Note stage of pregnancy at which x-ray therapy was administered.
45CASE 5. Patient M.T. Age 26. Para 1
History
In February 1960 noted lump in the left breast. Attended own doctor and referred
immediately to hospital.
Pre-Operative Findings




X-ray therapy March 1962.
Pathology Report
"Massive tumour 6 x 5 x 2 cms.-intraduct carcinoma which has spread extensively
outside the ducts and infiltrating widely."
Subsequent History
Became pregnant in October 1968-8 months later.
In March 1963 developed recurrence and metastases in scapula.
June 1963-Caesarean section under local anaesthetic.
Child died 2 hours later.
Patient died 1 week later
Comment
The pathology report would suggest that the patient should have been advised against
further pregnancy for at least two years. Prognosis probably poor even if pregnancy had
not supervened.
CASE 6. Patient M.C. Age 42. Para 4
History
In August 1962 patient noticed swelling in upper part of chest. Then noticed swelling
in outer part of left breast.
Pre-Operative Findings
Large mass in outer part of left breast. No nodes. Hard. fixed swelling upper end of





Simple mastectomy and removal of accessible nodes-27.9.1962.
X.R.T. to chest wall and sternum-October 1962.
Pathology Report
"Anaplastic spheroidal cell infiltrating widely." No mention of nodes.
Subsequent History
Admitted to maternity hospital 7.12.1962. Had caesarean section for placenta praevia.
Child alive and well.
Ovaries inspected but not removed.
Has remained well since. X-rays indicate recalcification of sternum.
Well five years later.
Comment
Not included in 5 year survival results. Following treatment patient was only seen again
some days after section.
46